H
HROW
Harrow Health Inc
41.50
+0.85+2.09%After Hours: 41.79 +0.29 +0.70%19:59 04/17 EDT
OPEN/PREV CLOSE41.16/40.65
TODAY RANGE40.26-42.13
VOL777.02K
MARKET CAP1.55B
52 WEEK RANGE21.12-54.85
AVG VOL (3M)709.75K
% TURNOVER2.09%
TURNOVER--
P/E (TTM)-296.8526
% RANGE4.60%
EPS(TTM)-0.1398
P/E(FORWARD)83.00
P/B29.46
BVPS1.409
DIVIDEND--
P/S5.67
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.29B
SHARES OUTSTANDING37.23M
NEXT EARNINGS05/06-05/11
FREE FLOAT31.07M
LOT SIZE1
EX-DATE02/08/2013
News
Press Releases
Financial Reports
Profile
Dow Jones·1d ago
Harrow Price Target Maintained With a $63.00/Share by BTIG
Benzinga·1d ago
BTIG Reiterates Buy on Harrow, Maintains $63 Price Target
TipRanks·2d ago
Harrow announces issuance of J-Code for Iopidine 1%
Dow Jones·2d ago
Press Release: Harrow Announces the Issuance of -2-
Barchart·2d ago
Harrow Announces the Issuance of J-Code for IOPIDINE® 1%
Seeking Alpha·3d ago
FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides
TipRanks·4d ago
Harrow selects LogiCare3PL as distribution partner
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.